RABIGEN MULTI
RABIGEN MULTI
Authorised
- Rabies virus, strain VP12, Inactivated
Product identification
Medicine name:
RABIGEN MULTI
Active substance:
- Rabies virus, strain VP12, Inactivated
Target species:
-
Dog
-
Cat
-
Horse
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabies virus, strain VP12, Inactivated1.00/international unit(s)1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
- Cat
- Horse
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- National Veterinary Medicines Agency
Authorisation number:
- FR/V/9194650 6/2010
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 26/03/2024
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 22/05/2023
How useful was this page?:
